A protein that promotes the growth of neurons and blood vessels may halt the spread of a brain disease that ravages the cerebellum. The disease, spinocerebellar ataxia type 1, typically strikes people in their 30s and 40s and causes degeneration of the part of the brain that helps coordinate movement. As the disease progresses over 10 to 20 years, patients eventually die from aspiration or infectious pneumonia.